Research: Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer
22 Mar, 2018 | 23:48h | UTCEffect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)
Commentaries: Higher doses of radiation don’t improve survival in prostate cancer: Side effects also a concern – Washington University School of Medicine, via ScienceDaily (free) AND Higher doses of radiation don’t improve overall survival for prostate cancer patients – OnMedica (free)